Viatris

Health Care Pharmaceuticals Pittsburgh, Pennsylvania Last filing Feb 26, 2026 · FY2025

                    Revenue
                    FY2025
                
$14.3B
                    3y CAGR -4.2%
                    
                    P8
                    
                    -3.0%
                    
                    Net income
                    FY2025
                
$-3.5B
                    Net margin -24.7%
                    
                    P3
                    
                    -454.2%
                    
                    Total assets
                    FY2025
                
$37.2B
                    ROA -9.5%
                    
                    P3
                    
                    -10.4%
                    
                    Operating cash flow
                    FY2025
                
$2.3B
                    FCF margin +13.6%
                    
                    P39
                    
                    +0.6%

10 yrs · FY2016–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years

Total assets $37.2B

Total liabilities $22.5B

Shareholders equity $14.7B

Account	2025	2024	2023	2022	2021
Assets
Cash and Cash Equivalents	9.3%	5.0%	6.4%	7.8%	3.9%
Accounts Receivable	21.3%	21.9%	24.0%	23.5%	24.0%
Inventory	28.1%	26.2%	22.5%	21.7%	22.3%
Prepaid Expenses	10.1%	11.6%	13.2%	11.2%	11.0%
Other Current Assets	1.0%	2.6%	1.8%	8.7%	8.2%
Total Current Assets	68.7%	64.8%	84.3%	65.6%	61.2%
Property,Plant and Equipment	18.3%	18.1%	17.9%	18.6%	17.9%
Operating Lease Assets	1.9%	1.7%	1.6%	1.6%	1.6%
Goodwill	47.4%	62.2%	64.1%	64.3%	68.0%
Intangible Assets	106.0%	116.2%	124.6%	139.4%	146.7%
Deferred Tax Assets	7.4%	5.1%	4.5%	5.7%	7.5%
Other Noncurrent Assets	13.1%	16.0%	14.4%	14.8%	6.6%
Total Assets	261.0%	282.5%	309.9%	308.4%	307.9%
Liabilities
Accounts Payable	12.3%	12.6%	12.6%	10.9%	9.3%
Accrued Liabilities	5.6%	7.8%	5.8%	6.0%	7.0%
Current Portion of Long Term Debt	13.6%	0.1%	12.6%	7.8%	10.5%
Operating Lease Liabilities	0.8%	0.6%	0.5%	0.5%	0.5%
Other Current Liabilities	23.0%	25.4%	22.1%	21.2%	25.9%
Total Current Liabilities	49.8%	39.3%	50.5%	41.6%	55.5%
Long Term Debt	87.6%	95.5%	105.2%	111.1%	110.7%
Operating Lease Liabilities Noncurrent	1.2%	1.2%	1.1%	1.1%	1.1%
Deferred Tax Liabilities	6.3%	7.5%	11.3%	15.0%	15.8%
Other Noncurrent Liabilities	14.1%	13.2%	9.9%	10.8%	10.9%
Total Liabilities	157.8%	155.6%	176.9%	178.5%	192.8%
Equity
Common Stock	0.1%	0.1%	0.1%	0.1%	0.1%
Additional Paid In Capital	131.9%	128.8%	122.3%	115.0%	104.1%
Retained Earnings	-2.7%	23.3%	30.2%	31.9%	20.7%
Treasury Stock	7.1%	3.4%	1.6%	0.0%	0.0%
Accumulated Other Comprehensive Income	-19.0%	-21.9%	-17.9%	-17.0%	-9.8%
Total Stockholders Equity	103.2%	126.8%	133.0%	129.9%	115.0%
Total Liabilitiesand Equity	261.0%	282.5%	309.9%	308.4%	307.9%

Income Statement

Revenue, expense, and profitability

17 accounts · 5 years

Revenue $14.3B

Operating income $-2.7B

Net income $-3.5B

Account	2025	2024	2023	2022	2021
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%	100.0%	100.0%
Expenses Cost of Revenue	65.2%	62.0%	58.4%	60.2%	69.1%
Expenses Research and Development	6.8%	5.5%	5.2%	4.1%	4.2%
Expenses Selling,General and Administrative	26.6%	27.9%	26.4%	25.8%	25.4%
Expenses Depreciation and Amortization	19.6%	19.7%	17.8%	18.7%	25.3%
Expenses Share Based Compensation	1.2%	1.0%	1.2%	0.7%	0.6%
Expenses Operating Expenses	53.9%	38.2%	36.9%	30.1%	31.5%
Other Income Expense Gross Profit	35.2%	38.3%	41.8%	40.1%	31.3%
Other Income Expense Operating Income	-18.7%	0.1%	5.0%	10.0%	-0.2%
Other Income Expense Interest Expense	3.3%	3.7%	3.7%	3.7%	3.6%
Other Income Expense Other Income/expense	-3.7%	-0.6%	0.1%	11.0%	0.0%
Other Income Expense Income Before Tax	-25.7%	-4.2%	1.3%	17.3%	-3.7%
Income Tax Income Tax Expense	-1.1%	0.1%	1.0%	4.5%	3.4%
net Income net Income	-24.7%	-4.3%	0.4%	12.8%	-7.1%
net Income Comprehensive Income	3.6%	-3.2%	0.1%	-6.3%	-5.0%
Earnings Per Share Basic Eps	-0.0%	-0.0%	0.0%	0.0%	-0.0%
Earnings Per Share Diluted Eps	-0.0%	-0.0%	0.0%	0.0%	-0.0%

Cash Flow Statement

Operating, investing, and financing flows

24 accounts · 5 years

Operating cash flow $2.3B

Investing cash flow $-427.7M

Financing cash flow $-1.3B

Account	2025	2024	2023	2022	2021
CashFlow
Operating Activities net Income	-24.7%	-4.3%	0.4%	12.8%	-7.1%
Operating Activities Depreciation and Amortization	19.6%	19.7%	17.8%	18.7%	25.3%
Operating Activities Stock Based Compensation	1.2%	1.0%	1.2%	0.7%	0.6%
Operating Activities Deferred Income Taxes	-3.3%	-5.2%	-2.5%	-0.2%	3.8%
Operating Activities Changes In Operating Assets and Liabilities	-1.6%	2.9%	3.5%	3.1%	2.1%
Operating Activities net Cash From Operating Activities	16.3%	15.7%	18.8%	18.5%	16.9%
Investing Activities Capital Expenditures	2.7%	2.2%	2.4%	2.5%	2.6%
Investing Activities Business Acquisitions	0.0%	2.4%	4.3%	0.0%	-1.6%
Investing Activities Purchases of Investments	0.2%	0.2%	0.2%	0.2%	0.2%
Investing Activities Proceeds From Sale of Investments	0.2%	0.2%	0.2%	0.2%	0.2%
Investing Activities Other Investing Activities	0.2%	0.1%	0.6%	0.2%	0.3%
Investing Activities net Cash From Investing Activities	-3.0%	12.3%	-5.6%	9.1%	-0.7%
Financing Activities Proceeds From Debt	0.0%	0.0%	0.0%	11.6%	9.6%
Financing Activities Repayment of Debt	0.0%	25.3%	8.1%	22.6%	23.6%
Financing Activities Repurchase of Common Stock	3.5%	1.7%	1.6%	0.0%	0.0%
Financing Activities Dividends Paid	4.0%	4.0%	3.8%	3.6%	2.3%
Financing Activities Proceeds From Stock Issuance	0.0%	0.0%	0.0%	0.0%	0.0%
Financing Activities Tax Withholding On Stock Based Compensation	0.2%	0.4%	0.2%	0.1%	0.1%
Financing Activities Other Financing Activities	-1.3%	2.0%	-1.1%	0.1%	-0.0%
Financing Activities net Cash From Financing Activities	-9.1%	-29.5%	-15.0%	-23.9%	-16.9%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	-0.2%	-0.0%	-0.2%	-0.2%
Cash Reconciliation net Change In Cash	4.3%	-1.8%	-1.7%	3.4%	-0.8%
Cash Reconciliation Cash At Beginning of Period	9.5%	5.0%	6.5%	7.8%	4.0%
Cash Reconciliation Cash At End of Period	9.5%	5.0%	6.5%	7.8%	4.0%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2025	2024	2023	2022	2021
Profitability
Gross margin	+34.8%	+38.0%	+41.6%	+39.8%	+30.9%
Operating margin	-18.7%	+0.1%	+5.0%	+10.0%	-0.2%
Net margin	-24.7%	-4.3%	+0.4%	+12.8%	-7.1%
FCF margin	+13.6%	+13.5%	+16.4%	+16.0%	+14.4%
Growth
Revenue CAGR (3y)	-4.2%	-6.2%	+9.2%	+12.6%	+16.5%
Returns
ROE	-23.9%	-3.4%	+0.3%	+9.9%	-6.2%
ROA	-9.5%	-1.5%	+0.1%	+4.2%	-2.3%
ROIC	-9.6%	+0.0%	+0.5%	+3.1%	-0.1%
Liquidity
Current ratio	1.38x	1.65x	1.67x	1.58x	1.10x
Quick ratio	0.61x	0.68x	0.60x	0.75x	0.50x
Leverage
D/E	1.53x	1.23x	1.33x	1.37x	1.68x
Interest coverage	-5.65x	0.02x	1.34x	2.73x	-0.05x
Efficiency
Asset turnover	0.38x	0.35x	0.32x	0.32x	0.32x
Cash conversion cycle	+166d	+160d	+150d	+151d	+156d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Viatris

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history